NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Waaree Energies Calls Urgent Investor Meet on U.S. Solar Import Duties
Waaree Energies Limited has convened an emergency analyst call on February 25, 2026, to address recent news concerning U.S. duties on Indian solar imports. The meeting, scheduled for 1:30 PM IST, involves top leadership including the CEO and CFO to provide clarity on trade developments. This urgent disclosure follows specific SEBI guidelines for rapid investor communication on material events. The outcome is critical as the U.S. is a major market for Indian solar module manufacturers.
முக்கிய அம்சங்கள்
Conference call scheduled for February 25, 2026, at 1:30 PM IST on short notice.Focus on clarifying the impact of new U.S. import duties on Indian solar products.Participation from CEO Amit Paithankar and CFO Sonal Shrivastava.Compliant with SEBI circular dated February 25, 2025, regarding shorter notice periods.
👀 கவனிக்க வேண்டியவை
Closely track the management's commentary regarding the potential impact on export margins and order books. The stock may experience volatility until the financial implications of the U.S. duties are quantified.
Waaree Energies Clarifies on US Solar Tariffs; Confirms No Undisclosed Price Sensitive Info
Waaree Energies has addressed stock exchange queries regarding news of US solar tariffs which led to a 5-10% decline in its stock price on February 25, 2026. The company stated that the preliminary countervailing duties imposed by the U.S. Department of Commerce are industry-wide regulatory measures affecting the entire solar sector. It confirmed that there is no unpublished price sensitive information (UPSI) and that the recent price movement is entirely market-driven. No legal or regulatory proceedings have been initiated against the company in this context.
முக்கிய அம்சங்கள்
Responded to BSE/NSE clarification requests regarding news of US tariff impacts on solar stocksNoted that the stock had trimmed losses after falling 5-10% following the tariff newsConfirmed that the U.S. Department of Commerce's tariff measures are industry-wide and not company-specificAsserted full compliance with SEBI Regulation 30 and confirmed no pending UPSI
👀 கவனிக்க வேண்டியவை
Investors should monitor the final duty rates from the US Department of Commerce as they will impact export competitiveness. The stock remains sensitive to US trade policy changes given its significant export focus.
Waaree Energies Responds to 126% U.S. Import Duty; Targets 4.2 GW U.S. Capacity by FY27
Waaree Energies is addressing the U.S. Department of Commerce's preliminary 126% countervailing duty on Indian solar imports, a sharp rise from previous levels. To mitigate this, the company is leveraging its current 2.6 GW U.S. manufacturing capacity and plans to expand it to 4.2 GW by FY27. Additionally, it is diversifying its supply chain with investments in Oman for non-Chinese polysilicon to ensure compliance and resilience. Management believes these localized production efforts will allow them to fulfill U.S. orders without material adverse impacts.
முக்கிய அம்சங்கள்
U.S. Dept of Commerce imposed preliminary 126% countervailing duties on Indian solar imports.Waaree currently operates 2.6 GW of U.S. module manufacturing capacity, including the Meyer Burger facility.Expansion plan to reach 4.2 GW U.S. capacity by the end of FY27 is currently underway.Strategic investments in Oman for non-Chinese polysilicon to ensure supply chain traceability and resilience.Management expects no material impact on servicing the U.S. order book due to localized manufacturing hedge.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the final duty determination and the execution speed of the U.S. capacity expansion to 4.2 GW. The company's ability to shift production to its U.S. facilities is a critical buffer against these high import tariffs.
Thyrocare Infuses Additional USD 475,000 in Tanzania Subsidiary via CCPS
Thyrocare Technologies has invested an additional USD 475,000 (approx. INR 4.33 Crores) into its subsidiary, Thyrocare Laboratories (Tanzania) Limited. This capital infusion was executed through Compulsorily Convertible Irredeemable Preference Shares (CCPS) to support working capital and business operations. The total investment in the Tanzanian venture now reaches approximately INR 10.02 Crores, against a board-approved limit of INR 15 Crores. While the subsidiary is scaling with a turnover of INR 1.84 Crores in 2025, it currently reports a negative net worth of INR 0.32 Crores.
முக்கிய அம்சங்கள்
Additional investment of USD 475,000 (INR 4.33 Crores) via subscription to CCPS.Total cumulative investment in the Tanzanian subsidiary now stands at INR 10.02 Crores.Thyrocare Tanzania reported a turnover of INR 1.84 Crores for the year ended December 31, 2025.The company maintains a 57.25% equity stake and 100% CCPS holding in the joint venture.Board approval allows for a total investment of up to INR 15 Crores in one or more tranches.
👀 கவனிக்க வேண்டியவை
Investors should monitor the turnaround and scaling of the Tanzanian operations, as the subsidiary currently has a negative net worth. While the investment amount is small relative to Thyrocare's balance sheet, it reflects the company's commitment to international expansion.
Waaree Energies Subsidiary Secures 300MW Wind Power Project from SECI
Waaree Energies' wholly-owned subsidiary, Waaree Forever Energies Private Limited, has received a Letter of Award from the Solar Energy Corporation of India (SECI). The contract involves the development of a 300MW Wind Power Project located in Dwarka, Gujarat. This project includes a Power Purchase Agreement (PPA) that will be valid for a long-term duration of 25 years from the commencement of supply. This win signifies the company's successful expansion into the wind energy segment alongside its established solar business.
முக்கிய அம்சங்கள்
Awarded a 300MW Wind Power Project in Dwarka, Gujarat by SECISecured a long-term Power Purchase Agreement (PPA) valid for 25 yearsProject to be executed via wholly-owned subsidiary Waaree Forever Energies Private LimitedStrengthens the company's renewable energy portfolio beyond solar manufacturing
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for long-term revenue visibility and business diversification. Monitor the company's execution progress and any upcoming capital expenditure plans related to this wind project.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Waaree Energies Bags 500MW Solar Module Supply Order for FY 2026-27
Waaree Energies Limited has secured a significant domestic order for the supply of 500MW solar modules. The contract was awarded by a prominent solar power developer and Independent Power Producer (IPP) in India. The supply is scheduled to be executed during the 2026-27 financial year, providing strong revenue visibility for the company. This order underscores Waaree's competitive position in the domestic solar manufacturing market.
முக்கிய அம்சங்கள்
Secured a major order for the supply of 500MW solar modules to a domestic entity.The customer is a renowned solar power developer and Independent Power Producer (IPP).The entire supply of modules is scheduled for completion within the FY 2026-27 period.The contract is a one-time supply agreement and is not a related party transaction.
👀 கவனிக்க வேண்டியவை
This order provides clear revenue visibility for the next fiscal year; investors should remain positive while monitoring the company's execution efficiency and margin protection.
Share India to Invest ₹6 Crore in Subsidiary Share India Cred Capital via Rights Issue
Share India Securities has approved an additional investment of ₹5.99 crore in its subsidiary, Share India Cred Capital Private Limited (SICCPL). The company will acquire 59,93,994 equity shares at a face value of ₹10 each through a rights issue. SICCPL is a newly incorporated entity (January 2026) that will focus on structured credit, debt syndication, and pre-IPO equity deals. This capital infusion is aimed at strengthening the subsidiary's capital base to support its initial operations and expansion.
முக்கிய அம்சங்கள்
Acquisition of 59,93,994 equity shares at a face value of ₹10 per share for a total of ₹5.99 crore.Share India Securities will maintain its 60% majority stake in SICCPL following the rights issue subscription.Target entity SICCPL was recently incorporated on January 6, 2026, and operates in the financial services industry.The investment is expected to be completed within 5 working days from the disclosure date.SICCPL will focus on high-growth areas like debt syndication, structured credit, and trading in unlisted/pre-IPO securities.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine capital allocation to a new business vertical; monitor the subsidiary's performance in upcoming quarters to see its impact on consolidated margins. No immediate portfolio changes are recommended based on this modest investment size.
Waaree Energies Signs 2.5 MW EAAS Agreement and 50 MW Strategic MoU for Green Hydrogen
Waaree Energies' subsidiary has entered a 15-year Electrolyzer as a Service (EAAS) agreement with Zero Footprint Industries (ZFI) for a 2.5 MW project in Uttar Pradesh. The partnership also includes a strategic MoU to supply 50 MW of electrolyzers for decentralized green hydrogen projects across Northern India. The initial project aims to produce 41 lakh Nm3 of green hydrogen annually, with commercial operations slated for Q3 FY 2026-27. This move establishes Waaree as a key player in the green hydrogen infrastructure and services market.
முக்கிய அம்சங்கள்
Signed a 15-year long-term contract for a 2.5 MW alkaline electrolyzer project in Uttar PradeshStrategic MoU for 50 MW of electrolyzer supply via the Electrolyzer as a Service (EAAS) modelInitial project targets annual production of 41 lakh Nm3 of green hydrogen and 20 lakh Nm3 of green oxygenFast-track execution with commercial operations expected by Q3 FY 2026-27Potential to scale capacity to 10,000 m3/hr across multiple locations over the next five years
👀 கவனிக்க வேண்டியவை
This deal validates Waaree's technology in the green hydrogen space and introduces a recurring revenue model through EAAS. Investors should monitor the timely commissioning of the first project as a benchmark for the larger 50 MW MoU.
Religare Enterprises Q3 FY26 Income Rises to ₹2,067.9 Cr; Care Health AUM Crosses ₹10,000 Cr
Religare Enterprises reported a consolidated total income of ₹2,067.9 crores for Q3 FY26, up from ₹1,670.2 crores in the same quarter last year. Despite revenue growth, the company posted a consolidated loss before tax of ₹103.1 crores, impacted by one-time employee benefit provisions under the new labor code. The insurance subsidiary, Care Health, remains a strong performer with retail business growing 41% and its AUM crossing the ₹10,000 crore milestone. Governance remains a focal point with the proposed induction of Burman family members and Jimeet Modi to the Board.
முக்கிய அம்சங்கள்
Consolidated total income increased to ₹2,067.9 crores in Q3 FY26 vs ₹1,670.2 crores in Q3 FY25.Care Health Insurance retail premium grew by 41% YoY, with total 9M premium reaching ₹7,906 crores.Care Health AUM crossed ₹10,000 crores with a solvency ratio of 1.70 as of December 2025.One-time wage code provisions of ₹13.5 crores impacted quarterly profitability in the insurance segment.Board expansion proposed to include Dr. Anand Burman, Mohit Burman, Aditya Chand Burman, and Jimeet Modi.
👀 கவனிக்க வேண்டியவை
Investors should monitor the transition in board leadership and the impact of the new management team on long-term strategy. While the consolidated loss is a concern, the robust growth and market share gains in the health insurance subsidiary provide a strong underlying valuation support.
Saregama Incorporates Wholly Owned Subsidiary in Dubai with AED 1 Million Capital
Saregama India Limited has successfully incorporated a new wholly owned subsidiary in Dubai, UAE, named 'Saregama Performing Arts and Music Festivals L.L.C S.O.C'. The entity is established with a share capital of AED 1,000,000, consisting of 1,000 shares at AED 1,000 each. This move aims to expand the company's footprint in the digital entertainment and live events space, specifically focusing on music festivals, artist talent contracting, and theatrical productions. The incorporation follows a board approval granted in September 2025, marking a strategic push into the Middle Eastern market.
முக்கிய அம்சங்கள்
Incorporated 'Saregama Performing Arts and Music Festivals L.L.C S.O.C' as a 100% subsidiary in Dubai MainlandThe subsidiary has a total share capital of AED 1,000,000 (approx. INR 2.25 Crores) distributed into 1,000 sharesBusiness focus includes live events, music festivals, artist contracting, and theatrical show productionThe Certificate of Incorporation and Commercial License were issued on February 20, 2026
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's execution in the live events and artist management space in the UAE. This diversification into global live entertainment could provide a high-margin revenue stream beyond traditional music licensing.
Bajaj Healthcare Shareholders Approve Re-appointment of CMD and 6 Other Directors
Bajaj Healthcare Limited has successfully passed seven special resolutions via postal ballot as of February 19, 2026. Key approvals include the re-appointment of Mr. Sajankumar Rameshwarlal Bajaj as Chairman & Managing Director and Mr. Anil Champalal Jain as Managing Director. The company also appointed three new Non-Executive Independent Directors to its board. While all resolutions passed with the requisite majority, Resolution 7 faced significant dissent from public institutional voters.
முக்கிய அம்சங்கள்
Re-appointment of Sajankumar Rameshwarlal Bajaj as CMD passed with 99.99% of total votes in favor.Three new Independent Directors (Mr. Vaghela, Mrs. Amin, and Mr. Bhavsar) were officially inducted into the board.Total of 19.3 million votes were polled, representing 61.13% of the total outstanding shares.Resolution 7 regarding the re-appointment of Mr. Pakshal Anil Jain saw 99.99% of voting public institutions (599,840 votes) voting against.All 7 resolutions were special resolutions and passed with the required majority as per SEBI regulations.
👀 கவனிக்க வேண்டியவை
The approval ensures management continuity, which is generally stable for the stock. However, investors should monitor the reasons behind the high institutional dissent on Resolution 7 to evaluate any underlying corporate governance concerns.
Waaree Energies has clarified news reports regarding a proposed ₹8,175 crore battery giga-factory investment in Andhra Pradesh. The company confirmed that its Board had previously approved a capacity expansion from 3.5 GWh to 20 GWh for Lithium-Ion cells and Battery Energy Storage Systems (BESS) in October 2025. This expansion involves a capital expenditure of approximately ₹8,000 crores through its subsidiary, Waaree Energy Storage Solutions. While discussions with the Andhra Pradesh government and other states are ongoing for a greenfield facility, no new material development beyond the 2025 disclosure has occurred.
முக்கிய அம்சங்கள்
Confirmed planned capacity expansion from 3.5 GWh to 20 GWh for Lithium-Ion cells and BESSAllocated capital expenditure of approximately ₹8,000 crores for the expansion projectActively in discussions with the Government of Andhra Pradesh and other states for a greenfield facilityExpansion is being executed through wholly owned subsidiary Waaree Energy Storage Solutions Private LimitedThe ₹8,000 crore capex plan was originally approved by the Board on October 01, 2025
👀 கவனிக்க வேண்டியவை
Investors should view the confirmation of the massive ₹8,000 crore capex as a long-term growth driver in the energy storage space. Monitor for official MoUs with state governments which will provide clarity on project timelines and incentives.
Hindware Home Innovation Q3 FY26: EBITDA Jumps 38% to ₹52 Cr; Roorkee Plant Commences Operations
Hindware Home Innovation reported a steady Q3 FY26 with consolidated revenue growing 8% YoY to ₹640 crore and EBITDA rising 38% to ₹52 crore. The Bathware segment saw 14% revenue growth driven by premiumization, with premium products now contributing 40% of its revenue. The company is strategically discontinuing loss-making consumer categories like fans and air purifiers to focus on high-margin kitchen appliances, targeting a segment revenue of ₹650-700 crore by FY31. While the Pipes business faced resin price volatility, the new Roorkee plant is expected to add ₹200 crore in annual revenue once fully ramped up.
முக்கிய அம்சங்கள்
Consolidated Q3 FY26 EBITDA grew 38% YoY to ₹52 crore with margins improving from 6% to 8%.Bathware segment revenue increased 14% YoY to ₹386 crore, supported by a 5-day improvement in working capital cycles.Strategic exit from loss-making categories (fans, air purifiers, furniture fittings) to focus on kitchen appliances and water heaters.Roorkee Pipes plant commenced commercial production in Jan 2026, targeting ₹200 crore incremental annual revenue.9M FY26 PBT before exceptional items turned positive at ₹30 crore compared to a loss of ₹30 crore in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should view the strategic rationalization of the consumer portfolio and the commencement of the Roorkee plant as positive catalysts for margin expansion. Monitor the execution of the premiumization strategy in Bathware and the stabilization of resin prices in the Pipes segment.
Amara Raja Q3 FY26: Revenue Up 4.2% to ₹3,410 Cr; New Energy Segment Revenue Doubles
Amara Raja Energy & Mobility reported a consolidated revenue of INR 3,410 crores for Q3 FY26, a 4.2% YoY growth. While the lead-acid business remains the primary driver, the New Energy segment crossed the INR 200 crore milestone, doubling its revenue compared to the previous year. The company faced headwinds in exports, which declined 15%, and telecom lead-acid volumes, which fell over 45% due to lithium transition. To counter raw material cost pressures, a 2% price hike was implemented in January 2026, and the board approved a new 5 GWh BESS plant with a ₹280 crore outlay.
முக்கிய அம்சங்கள்
Consolidated revenue reached INR 3,410 crores with 4-wheeler OEM volumes growing 25% YoY.New Energy business revenue doubled YoY to over INR 200 crores, driven by telecom lithium pack demand.Board approved a 5 GWh integrated BESS plant with INR 280 crore investment, expected operational by FY27-end.Standalone operating margins were 11.2%, but adjusted for recycling efficiencies and trading, margins stood at 12.3%.YTD December capex stood at INR 950 crores, with FY27 New Energy capex projected at INR 1,000 crores.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's aggressive transition toward New Energy and BESS solutions as lead-acid telecom demand fades. Monitor the margin recovery in Q4 following the January price hike and the progress of the lithium cell subsidiary investments.
Religare Enterprises Reports Q3 FY26 Net Loss of ₹76.5 Cr; Care Health GWP Grows to ₹7,906 Cr
Religare Enterprises Limited (REL) reported a consolidated net loss of ₹76.5 crore for Q3 FY26, compared to a loss of ₹63.2 crore in the same period last year. While total income grew by 23.8% YoY to ₹2,067.9 crore, rising expenses and higher claims in the insurance segment weighed on profitability. Care Health Insurance remains the primary growth engine, contributing ₹7,906 crore in GWP for 9M FY26 with a 22% market share in the SAHI segment. The company's NBFC arm, Religare Finvest, is now debt-free with over ₹500 crore in cash reserves following successful NPA recoveries.
முக்கிய அம்சங்கள்
Consolidated Total Income increased 23.8% YoY to ₹2,067.9 crore in Q3 FY26.Care Health Insurance GWP grew to ₹7,906 crore for 9M FY26, up from ₹6,508 crore YoY.Consolidated Net Loss for 9M FY26 stood at ₹22.5 crore versus a profit of ₹32 crore in 9M FY25.Care Health's AUM crossed a significant milestone, reaching ₹10,246 crore as of December 2025.Religare Finvest (NBFC) has resolved legacy issues and maintains a cash balance of ₹500+ crore.
👀 கவனிக்க வேண்டியவை
Investors should focus on the improving operational metrics of Care Health and the debt-free status of the NBFC arm, while remaining cautious about the widening consolidated losses. Monitor the combined ratio in the insurance business, which rose to 111.1% in Q3 FY26, as a key indicator of future profitability.
Religare Enterprises Announces Strategic Demerger of Financial Services; 1:1 Share Swap Ratio
Religare Enterprises (REL) has approved a demerger to separate its financial services and insurance businesses into two independent listed entities. The financial services business, including lending and broking, will be transferred to Religare Finvest Limited (RFL), while REL will retain the insurance business through Care Health Insurance. Shareholders will receive 1 share of RFL for every 1 share held in REL. The demerged undertaking contributed ₹457.29 crore (6.2%) to the consolidated turnover in FY25.
முக்கிய அம்சங்கள்
Demerger of lending, broking, and investment activities into Religare Finvest Limited (RFL)Shareholders to receive 1 fully paid-up equity share of RFL for every 1 share held in RELDemerged business accounted for ₹457.29 crore (6.2%) of FY25 consolidated turnoverREL to remain an insurance-focused entity holding the stake in Care Health Insurance LimitedRFL to be listed on BSE and NSE with a target completion date in Q1 FY28
👀 கவனிக்க வேண்டியவை
Investors should maintain their positions to benefit from the value unlocking of two distinct business platforms. Monitor the progress of regulatory approvals from the RBI and NCLT, as these are critical for the Q1 FY28 listing timeline.
Religare Enterprises Reports Q3 FY26 Standalone Net Loss of ₹11.31 Crore
Religare Enterprises reported a standalone net loss of ₹1,131.19 lakhs for the quarter ended December 31, 2025, a significant increase from the ₹397.38 lakhs loss reported in the previous quarter. Total income for the quarter plummeted to ₹238.61 lakhs from ₹759.58 lakhs in Q2 FY26, largely due to a sharp reduction in 'Other Income'. Expenses rose to ₹1,381.50 lakhs, primarily driven by employee benefit costs which more than doubled to ₹848.95 lakhs. The company continues to face ongoing income tax litigations, as noted by the statutory auditors in their limited review report.
முக்கிய அம்சங்கள்
Standalone net loss widened to ₹11.31 crore in Q3 FY26 compared to a loss of ₹3.97 crore in Q2 FY26.Total income declined by 68.6% quarter-on-quarter to ₹2.39 crore.Employee benefit expenses surged to ₹8.49 crore from ₹3.38 crore in the preceding quarter.The company reported a negative Earnings Per Share (EPS) of ₹0.34 for the quarter.Auditors included an 'Emphasis of Matter' regarding ongoing income tax litigations and related demands.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the standalone entity's losses are widening and operational expenses are rising. The focus should remain on the performance of its underlying subsidiaries in insurance and broking, as well as the resolution of legal and tax contingencies.
MT Educare Reports Q3 FY26 Net Loss of ₹1.87 Crore Amid Ongoing Insolvency Process
MT Educare Limited reported a net loss of ₹187.15 lakhs for the quarter ended December 31, 2025, which narrowed from a loss of ₹363.94 lakhs in the same quarter last year. Revenue from operations saw a significant jump to ₹244.97 lakhs compared to ₹98.23 lakhs year-on-year. The company remains under the Corporate Insolvency Resolution Process (CIRP) since December 2022, and the statutory auditors have issued a 'Disclaimer of Conclusion' on these results. This disclaimer indicates that the auditors were unable to obtain sufficient evidence to verify the carrying amounts of assets, liabilities, and the overall impact of the insolvency proceedings.
முக்கிய அம்சங்கள்
Revenue from operations increased to ₹244.97 lakhs in Q3 FY26 from ₹98.23 lakhs in Q3 FY25.Net loss for the quarter stood at ₹187.15 lakhs, showing improvement over the ₹363.94 lakhs loss in the previous year's corresponding period.Statutory auditors issued a Disclaimer of Conclusion due to non-availability of balance confirmations and non-determination of fair value for financial assets.The company did not recognize interest expenses of ₹87.55 lakhs for the quarter on defaulted bank borrowings.Management did not account for interest income of ₹573.09 lakhs for the quarter on long-outstanding overdue loans.
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as the company is undergoing insolvency proceedings and the financial results are not fully verifiable by auditors. There is a significant risk of capital erosion depending on the final resolution plan approved by the NCLT.
Hindware Home Innovation Q3 FY26: Revenue up 7.7% to ₹640 Cr, Returns to Profitability
Hindware Home Innovation reported a consolidated revenue of ₹640.08 crore for Q3 FY26, marking a 7.7% YoY growth. The company successfully turned profitable in its continuing operations with a net profit of ₹3.69 crore, a significant recovery from the ₹16.94 crore loss in Q3 FY25. The results were impacted by a strategic decision to exit high-loss consumer appliance categories, leading to a net exceptional charge of ₹44.28 crore for the nine-month period. The core Building Products segment continues to perform steadily, contributing nearly 87% of the total revenue.
முக்கிய அம்சங்கள்
Q3 Consolidated Revenue rose to ₹640.08 crore compared to ₹594.23 crore in the previous year.Net Profit for continuing operations stood at ₹3.69 crore vs a loss of ₹16.94 crore YoY.Building Products segment revenue grew to ₹558.71 crore from ₹526.88 crore YoY.9M FY26 performance includes a ₹44.28 crore exceptional loss related to the exit from non-core consumer categories.Restructuring via a Composite Scheme of Arrangement is underway to streamline business operations.
👀 கவனிக்க வேண்டியவை
The return to quarterly profitability and the exit from loss-making segments are positive structural changes. Investors should monitor the progress of the pending demerger and amalgamation scheme for long-term value unlocking.
Hindware Home Innovation Q3 FY26 Revenue Grows 6% YoY to ₹559 Cr; Bathware Leads Growth
Hindware Home Innovation reported a 6% YoY increase in Q3 FY26 revenue to ₹559 crore, primarily driven by a strong 14% growth in the Bathware segment. However, the Pipes business (TRUFLO) faced headwinds with revenue declining 8.5% YoY to ₹173 crore and sales volumes dropping to 10,327 MT. The company is currently undergoing a major corporate restructuring to demerge its consumer products business, which is pending NCLT approval. Profitability remains under pressure with a consolidated PBT margin of just 1.5% for the quarter, while net bank debt stood at ₹713 crore.
முக்கிய அம்சங்கள்
Q3 FY26 consolidated revenue rose to ₹559 crore compared to ₹527 crore in Q3 FY25.Bathware segment revenue grew 14% YoY to ₹386 crore with a stable EBITDA margin of 10%.Pipes business revenue fell to ₹173 crore from ₹189 crore YoY, with volumes declining by 8.3%.Commenced commercial production at the Roorkee plant on January 30, 2026, adding 12,500 tonnes of capacity.Composite Scheme of Arrangement for demerger and separate listing of entities is currently with NCLT Kolkata.
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the corporate restructuring which aims to unlock value by listing two separate entities. While Bathware shows resilience, the recovery of volumes in the Pipes segment and overall margin improvement are critical for a positive re-rating.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
